Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brendel W., Seifert J., Lob G. Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders. Proc R Soc Med. 1972 Jun;65(6):531–535. doi: 10.1177/003591577206500615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frick E. Zur immunsuppressiven Behandlung der Multiplen Sklerose. Nervenarzt. 1976 Jul;47(7):424–428. [PubMed] [Google Scholar]
- Jersild C., Dupont B., Fog T., Platz P. J., Svejgaard A. Histocompatibility determinants in multiple sclerosis. Transplant Rev. 1975;22:148–163. doi: 10.1111/j.1600-065x.1975.tb01556.x. [DOI] [PubMed] [Google Scholar]
- Knight S. C., Lance E. M., Abbosh J., Munro A., O'Brien J. Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro. Clin Exp Immunol. 1975 Jul;21(1):23–31. [PMC free article] [PubMed] [Google Scholar]
- Lance E. M., Kremer M., Abbosh J., Jones V. E., Knight S., Medawar P. B. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response. Clin Exp Immunol. 1975 Jul;21(1):1–12. [PMC free article] [PubMed] [Google Scholar]
- McFarlin D. E., Blank S. E., Kibler R. F. Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol. 1974 Aug;113(2):712–715. [PubMed] [Google Scholar]
- Mertin J., Meade C. J. Relevance of fatty acids in multiple sclerosis. Br Med Bull. 1977 Jan;33(1):67–71. doi: 10.1093/oxfordjournals.bmb.a071399. [DOI] [PubMed] [Google Scholar]
- Millar J. H., Zilkha K. J., Langman M. J., Wright H. P., Smith A. D., Belin J., Thompson R. H. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J. 1973 Mar 31;1(5856):765–768. doi: 10.1136/bmj.1.5856.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paterson P. Y. Multiple sclerosis: an immunologic reassessment. J Chronic Dis. 1973 Mar;26(3):119–126. doi: 10.1016/0021-9681(73)90085-4. [DOI] [PubMed] [Google Scholar]
- Ring J., Seifert J., Anstwurm H., Frick E., Mertin J., Brass B., Backmund H., Lob G. Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis. Postgrad Med J. 1976;52(5 Suppl):123–130. [PubMed] [Google Scholar]
- Rose A. S., Kuzma J. W., Kurtzke J. F., Namerow N. S., Sibley W. A., Tourtellotte W. W. Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report. Neurology. 1970 May;20(5):1–59. doi: 10.1212/wnl.20.5_part_2.1. [DOI] [PubMed] [Google Scholar]
- Seland T. P., Mc Pherson T. A., Grace M., Lamoureux G., Blain J. G. Evaluation of antithymocyte globulin in acute relapses of multiple sclerosis. Neurology. 1974 Jan;24(1):34–40. doi: 10.1212/wnl.24.1.34. [DOI] [PubMed] [Google Scholar]
- Sheremata W., Cosgrove J. B., Eylar E. H. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis. N Engl J Med. 1974 Jul 4;291(1):14–17. doi: 10.1056/NEJM197407042910104. [DOI] [PubMed] [Google Scholar]
- Smeraldi E., Scorza-Smeraldi R. Interference between anti-HLA antibodies and chlorpromazine. Nature. 1976 Apr 8;260(5551):532–533. doi: 10.1038/260532a0. [DOI] [PubMed] [Google Scholar]
- Svejgaard A., Ryder L. P. Interaction of HLA molecules with non-immunological ligands as an explanation of HLA and disease associations. Lancet. 1976 Sep 11;2(7985):547–549. doi: 10.1016/s0140-6736(76)91796-7. [DOI] [PubMed] [Google Scholar]
- Thompson E. J. Laboratory diagnosis of multiple sclerosis: immunological and biochemical aspects. Br Med Bull. 1977 Jan;33(1):28–33. doi: 10.1093/oxfordjournals.bmb.a071391. [DOI] [PubMed] [Google Scholar]
- Wiśniewski H. M. Immunopathology of demyelination in autoimmune diseases and virus infections. Br Med Bull. 1977 Jan;33(1):54–59. doi: 10.1093/oxfordjournals.bmb.a071397. [DOI] [PubMed] [Google Scholar]
